An interdisciplinary intervention for undertreated pediatric asthma

Natalie Walders1, Carolyn Kercsmar2, Mark Schluchter2

  • 1National Jewish Medical and Research Center, Denver, CO.

Chest
|February 16, 2006
PubMed

Insights

An interdisciplinary intervention for pediatric asthma did not improve symptoms but reduced emergency care visits. This approach offers a modest benefit for managing childhood asthma effectively.

Area of Science:

  • Pediatric Pulmonology
  • Healthcare Intervention Studies
  • Asthma Management

Background:

  • Pediatric asthma is a significant public health concern, often undertreated.
  • Lack of written treatment plans and frequent exacerbations characterize severe pediatric asthma cases.
  • Effective interventions are needed to reduce healthcare utilization and improve quality of life for children with asthma.

Purpose of the Study:

  • To evaluate the effectiveness of an interdisciplinary intervention for pediatric asthma.
  • To assess the impact of integrated care, education, and therapy on asthma outcomes.
  • To determine if the intervention reduces asthma-related healthcare utilization and improves quality of life.

Main Methods:

  • A randomized, controlled study was conducted at an urban tertiary-referral pediatric hospital.
  • 175 pediatric patients with uncontrolled asthma were randomized to either standard medical care or an interdisciplinary intervention.
  • The intervention included medical care, asthma education, problem-solving therapy, and a nurse advice line.

Main Results:

  • Both groups showed significant improvements in asthma symptoms and quality of life.
  • No significant between-group differences were observed in symptom reduction or quality of life.
  • The intervention group had significantly lower healthcare utilization, with 28% requiring emergency/inpatient services versus 41% in the control group.

Conclusions:

  • The interdisciplinary intervention did not improve asthma symptoms in pediatric patients.
  • The intervention demonstrated a modest but significant reduction in the utilization of acute medical care for asthma.
  • Integrated care approaches may be beneficial for reducing healthcare burden in pediatric asthma management.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...